An interventional study of Intrathecal atropine and dexamethasone in Postoperative Nausea, sponsored by Assiut University. Completed at 1 site in Egypt. Open to female participants aged 20 Years to 40 Years. Per ClinicalTrials.gov, last updated 2018-06-06.
Sponsored by Assiut University · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 82 studies testing dexamethasone in Postoperative Nausea and Vomiting — 10 open to participants now, 11 under way, 2 of them phase 3. Dexamethasone · Postoperative Nausea and Vomiting.
Among the 82 studies testing dexamethasone in Postoperative Nausea and Vomiting, this one is the 42nd largest by enrollment, is one of 6 that started in 2017, is one of 24 with no phase, and was the 45th registered.
638 studies on the registry are indexed under Postoperative Nausea and Vomiting; 110 are open to participants now.
Browse Postoperative Nausea and Vomiting studies →10 of the 82 studies testing dexamethasone in Postoperative Nausea and Vomiting are open now, in 7 countries. Recruiting first, the newest first:
Beijing Tiantan Hospital · Sites in China
Ages 18–65
Beijing Tiantan Hospital · Sites in China
Ages 18–65
Mansoura University · Sites in Egypt
Ages 18+
Balgrist University Hospital · Sites in Switzerland
Ages 18–99 · Healthy volunteers
University Medical Center Ho Chi Minh City (UMC) · Sites in Vietnam
Ages 18+ · Women only
By country, each count listing its studies:
Dexamethasone: first FDA approval 1958 (DECADRON), first EMA approval 2010. What it is approved for, and how studies give it, is on its page →
Of the 65 Postoperative Nausea and Vomiting studies recruiting now, 22 (34%) set no upper age limit and 37 (57%) stop at 75 or younger; 14 take children under 18; 11 take healthy volunteers.
This study: 20 Years to 40 Years · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
82 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 9 · Phase 3 12 · Phase 4 37
First in 2002; this study’s year is marked. 6 started in 2017.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 120 is close to the median of 112 across 529 interventional studies indexed under Postoperative Nausea and Vomiting.
Median enrollment 121 across the 82 interventional studies. Of the 59 that completed or were terminated, 16 (27%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 82 has an industry lead sponsor. The 10 most frequent:
Assiut University is the lead sponsor of 5,081 studies on the registry; 2,179 are open to participants now.
Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
14 studies in Postoperative Nausea and Vomiting by Assiut University: 4 open now, 4 under way, none of them phase 3. Of 7 finished, 0 (0%) have results posted.
Among the 14 studies in Postoperative Nausea and Vomiting by Assiut University, this one is the 3rd largest by enrollment of the 13 interventional ones that give a count, is the only one that started in 2017, is one of 5 with no phase, and was the 6th registered.
Assiut University’s Postoperative Nausea and Vomiting studies by the year they started, since 2015.
4 of the studies testing dexamethasone in Postoperative Nausea and Vomiting that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06997419Beijing Tiantan HospitalDexamethasone Palmitate for PONV After Open Surgery | 2026-11-30 |
| NCT07099222University of ArizonaEfficacy of Non-weight Based, Low Dose Dex-Dex Adjuncts in Prolonging Peripheral Nerve Blocks | 2026-12-31 |
| NCT06988124Beijing Tiantan HospitalDexamethasone Palmitate for PONV After Craniotomy | 2027-05-01 |
| NCT07615595University Medical Center Ho Chi Minh City (UMC)Dexamethasone to Prevent Side Effects of Spinal Anesthesia in Cesarean Delivery | 2027-07-31 |
Add all 4 to your calendar (.ics) → With an account.
Among the 82 studies testing dexamethasone in Postoperative Nausea and Vomiting, from their registry updates:
Among Assiut University’s 14 in Postoperative Nausea and Vomiting:
This tab as a report to print or save as PDF → With an account.
optimal postoperative pain control with intrathecal morphine, with proper prevention of postoperative nausea and vomiting. Dexamethasone, and or atropine could offer some protection against nausea and vomiting.
One of the gold standards for analgesia following cesarean delivery is intrathecal morphine, which is not devoid of complications namely postoperative nausea and vomiting. We evaluated the antiemetic effect of intravenous dexamethasone combined with intrathecal atropine after cesarean delivery under spinal bupivacaine plus morphine anesthesia.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Atropine group (A): Patients received intrathecal heavy Marcaine, 2 ml, 0.5% plus 300 µg morphine and 100 µg atropine (0.5ml), and intravenous injection of 2ml normal saline.
Drug: Intrathecal atropine
Dexamethasone group (D): Patients received intrathecal heavy Marcaine 2 ml, 0.5% plus 300 µg morphine (0.5ml), and intravenous 8 mg dexamethasone (2ml).
Drug: dexamethasone
Dexamethasone and Atropine group (DA): Patients received intrathecally as group A, plus intravenous injection of 2 ml, dexamethasone 8 mg. Postoperative follow-up of both nausea and vomiting was done over 24 hours postoperative.
Drug: Intrathecal atropine · Drug: dexamethasone
100ug intrathecal atropine will be injected with spinal anesthesia
intravenous 8 mg dexamethasone (2ml).
postoperative nausea
Monitoring scale of nausea and vomiting
Time frame: 24 hours
Plan to share: Undecided
No publications or documents are linked to this record.
Ran from Mar 2017 to primary completion in Jul 2017, 4 months.
Of 181 non-industry interventional studies with no phase under Postoperative Nausea and Vomiting, half reached primary completion within 13 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 26. This study's 4 months is below that.
Counting every sponsor, half of 181 studies reached it within 13 months; a quarter within 5 and three quarters within 26.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jun 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Atropine · Dexamethasone
Postoperative Nausea and Vomiting →